Profile data is unavailable for this security.
About the company
Abingdon Health plc is an international lateral flow contract research (CRO) and contract development and manufacturing organization (CDMO). The Company is engaged in offering its services to an international customer base across industry sectors that include clinical, animal health, plant health, and environmental testing. Its CDMO division offers product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. It focuses on supporting the increase in need for rapid results across many industries and locations and produces lateral flow tests in areas, such as infectious disease, clinical testing including companion diagnostics, and others. Its Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests. It also specializes in meeting compliance requirements in the international IVD and medical device markets.
- Revenue in GBP (TTM)5.34m
- Net income in GBP-2.24m
- Incorporated2008
- Employees82.00
- LocationAbingdon Health PLCYork Biotech Campus, Sand HuttonYORK YO41 1LZUnited KingdomGBR
- Phone+44 190 440 6050
- Fax+44 190 446 2122
- Websitehttps://www.abingdonhealth.com/
Mergers & acquisitions
| Acquired company | ABDX:LSE since announced | Transaction value |
|---|---|---|
| Compliance Solutions Group LLC | -13.49% | 4.12m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genedrive PLC | 272.00k | -5.00m | 10.46m | 43.00 | -- | 1.96 | -- | 38.44 | -0.0407 | -0.0407 | 0.0022 | 0.0098 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
| Genincode PLC | 2.16m | -7.02m | 11.95m | 36.00 | -- | 5.02 | -- | 5.53 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
| Ondine Biomedical Inc | 667.95k | -8.00m | 15.57m | 43.00 | -- | 11.00 | -- | 23.30 | -0.0407 | -0.0407 | 0.0034 | 0.0051 | 0.1079 | 0.4237 | 4.74 | -- | -129.24 | -- | -193.37 | -- | 58.44 | -- | -1,198.01 | -- | 1.06 | -- | 0.206 | -- | 88.56 | -- | 25.60 | -- | -- | -- |
| Renalytix PLC | 2.56m | -34.80m | 15.76m | 80.00 | -- | 0.6413 | -- | 6.15 | -0.4259 | -0.4259 | 0.0312 | 0.1481 | 0.0646 | 2.88 | 4.06 | 32,021.80 | -87.73 | -58.25 | -120.00 | -67.03 | 20.60 | -- | -1,358.30 | -1,904.79 | 1.71 | -9.62 | 0.397 | -- | 14.58 | -- | 18.52 | -- | -- | -- |
| Verici DX PLC | 3.26m | -3.62m | 16.37m | 19.00 | -- | 2.21 | -- | 5.02 | -0.0199 | -0.0199 | 0.0166 | 0.0306 | 0.4038 | -- | 5.71 | 232,988.50 | -44.82 | -- | -58.12 | -- | 77.06 | -- | -110.99 | -- | -- | -- | 0.0183 | -- | -- | -- | 23.43 | -- | -- | -- |
| Abingdon Health PLC | 5.34m | -2.24m | 18.01m | 82.00 | -- | 6.24 | -- | 3.37 | -0.0184 | -0.0184 | 0.0439 | 0.0149 | 0.8978 | 7.67 | 4.74 | 65,170.73 | -37.55 | -51.31 | -58.04 | -79.85 | 57.35 | 33.16 | -41.82 | -139.64 | 1.59 | -- | 0.3572 | -- | 42.68 | -- | 83.77 | -- | -- | -- |
| Polarean Imaging PLC | 1.41m | -6.43m | 19.01m | 29.00 | -- | 1.60 | -- | 13.52 | -0.0242 | -0.0242 | 0.0053 | 0.0099 | 0.1075 | 0.5109 | 1.84 | 48,502.78 | -49.18 | -61.45 | -58.32 | -69.17 | 44.78 | 50.68 | -457.39 | -810.92 | 5.24 | -- | 0.0093 | -- | -13.75 | -18.24 | 14.53 | -- | 64.51 | -- |
| Inspiration Healthcare Group PLC | 37.63m | -6.03m | 19.28m | 224.00 | -- | 0.5064 | -- | 0.5123 | -0.0883 | -0.0883 | 0.5516 | 0.4245 | 0.7243 | 1.67 | 3.87 | 167,991.10 | -11.61 | 1.04 | -14.18 | 1.28 | 47.53 | 47.61 | -16.04 | 1.16 | 0.9698 | -0.534 | 0.307 | -- | -8.74 | 19.43 | -2,318.38 | -- | 32.41 | -- |
| Belluscura PLC | 621.36k | -13.94m | 20.10m | 35.00 | -- | 1.23 | -- | 32.35 | -0.1056 | -0.1056 | 0.0048 | 0.0968 | 0.0372 | 0.3042 | 0.1975 | 17,753.15 | -83.37 | -49.84 | -96.68 | -54.78 | -116.54 | -66.07 | -2,243.45 | -1,277.34 | 1.71 | -3.43 | 0.00 | -- | -40.96 | 27.44 | -127.13 | -- | 41.32 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Octopus Investments Ltd.as of 14 Aug 2024 | 19.61m | 10.13% |
| Hargreaves Lansdown Asset Management Ltd.as of 08 Sep 2023 | 10.43m | 5.39% |
| Rathbones Investment Management Ltd.as of 14 Aug 2024 | 9.35m | 4.83% |
| Unicorn Asset Management Ltd.as of 31 Aug 2024 | 1.93m | 1.00% |
